Dynavax Technologies



Ebitda Cambiamento Data
AbbVie USD 4.4B 2.52B 2025-03
Adma Biologics USD 40.41M 1.17M 2024-12
Amgen USD 3.75B 42M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Dynavax Technologies USD -21594000 22.03M 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Merck USD 7.74B 625M 2025-03
Neurocrine Biosciences USD 31.3M 120.8M 2025-03
Novartis USD 6.17B 339M 2025-06
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -290408000 472.62M 2025-03
TG Therapeutics USD 29.96M 12.91M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12


Dynavax Technologies - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.